We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab and Olaparib in Cervical Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04483544
Recruitment Status : Recruiting
First Posted : July 23, 2020
Last Update Posted : November 10, 2022
Sponsor:
Collaborators:
Florida Department of Health
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Baptist Health South Florida

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2030
Estimated Study Completion Date : November 1, 2031